HealthpointCapital is currently running a series of blog posts in an attempt to answer the question: How will the credit crunch impact the orthopedic market?

The entire article, a conversation between Robin Young and John McCormick, is definitely worth a read, here’s just a small snippet:

“Taking the capital markets perspective, orthopedic stocks are nowhere near as badly shaken as the S&P 500 or – good grief – financials for that matter. Looking at some superficial fundamentals, in 1H:08 there has been encouraging revenue growth (currency gains notwithstanding) in the industry broadly. Importantly, the industry in aggregate is profitable and not leveraged. Without question, I’d rather be an employee of Zimmer versus Lehman Brothers right now.”

Read the full article here.